346 related articles for article (PubMed ID: 27259530)
1. Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence.
Lavikainen P; Helin-Salmivaara A; Eerola M; Fang G; Hartikainen J; Huupponen R; Korhonen MJ
BMJ Open; 2016 Jun; 6(6):e011306. PubMed ID: 27259530
[TBL] [Abstract][Full Text] [Related]
2. Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.
Rannanheimo PK; Tiittanen P; Hartikainen J; Helin-Salmivaara A; Huupponen R; Vahtera J; Korhonen MJ
Value Health; 2015 Sep; 18(6):896-905. PubMed ID: 26409618
[TBL] [Abstract][Full Text] [Related]
3. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
[TBL] [Abstract][Full Text] [Related]
4. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
[TBL] [Abstract][Full Text] [Related]
5. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China.
Zhao B; He X; Wu J; Yan S
BMC Cardiovasc Disord; 2020 Jun; 20(1):282. PubMed ID: 32522146
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
[TBL] [Abstract][Full Text] [Related]
7. Adherence to statin therapy and the incidence of ischemic stroke in patients with diabetes.
Korhonen MJ; Ruokoniemi P; Ilomäki J; Meretoja A; Helin-Salmivaara A; Huupponen R
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):161-9. PubMed ID: 26687512
[TBL] [Abstract][Full Text] [Related]
8. Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low-Risk Population With Type 2 Diabetes Mellitus.
Malmborg M; Schmiegelow MDS; Gerds T; Schou M; Kistorp C; Torp-Pedersen C; Gislason G
J Am Heart Assoc; 2021 Jul; 10(13):e020395. PubMed ID: 34151606
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review of the Effect of Adherence to Statin Treatment on Critical Cardiovascular Events and Mortality in Primary Prevention.
Martin-Ruiz E; Olry-de-Labry-Lima A; Ocaña-Riola R; Epstein D
J Cardiovasc Pharmacol Ther; 2018 May; 23(3):200-215. PubMed ID: 29343082
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
[TBL] [Abstract][Full Text] [Related]
11. Statins and hip fracture prevention--a population based cohort study in women.
Helin-Salmivaara A; Korhonen MJ; Lehenkari P; Junnila SY; Neuvonen PJ; Ruokoniemi P; Huupponen R
PLoS One; 2012; 7(10):e48095. PubMed ID: 23144731
[TBL] [Abstract][Full Text] [Related]
12. Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?
Aarnio E; Martikainen J; Winn AN; Huupponen R; Vahtera J; Korhonen MJ
Circ Cardiovasc Qual Outcomes; 2016 Nov; 9(6):704-713. PubMed ID: 27756795
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy.
Rublee DA; Chen SY; Mardekian J; Wu N; Rao P; Boulanger L
Am J Ther; 2012 Jan; 19(1):24-32. PubMed ID: 20838204
[TBL] [Abstract][Full Text] [Related]
14. Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan.
Chen ST; Huang ST; Shau WY; Lai CL; Li JZ; Fung S; Tse VC; Lai MS
BMC Cardiovasc Disord; 2019 Mar; 19(1):62. PubMed ID: 30876393
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases.
Corrao G; Scotti L; Zambon A; Baio G; Nicotra F; Conti V; Capri S; Tragni E; Merlino L; Catapano AL; Mancia G
Atherosclerosis; 2011 Aug; 217(2):479-85. PubMed ID: 21592477
[TBL] [Abstract][Full Text] [Related]
16. The effect of adherence to statin therapy on cardiovascular mortality: quantification of unmeasured bias using falsification end-points.
Bijlsma MJ; Vansteelandt S; Janssen F; Hak E
BMC Public Health; 2016 Apr; 16():303. PubMed ID: 27067123
[TBL] [Abstract][Full Text] [Related]
17. Statin adherence and risk of all-cause, cancer, and cardiovascular mortality among dyslipidemia patients: A time-dependent analysis.
Lee YR; Oh SS; Jang SI; Park EC
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2207-2214. PubMed ID: 32912787
[TBL] [Abstract][Full Text] [Related]
18. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.
Khunti K; Danese MD; Kutikova L; Catterick D; Sorio-Vilela F; Gleeson M; Kondapally Seshasai SR; Brownrigg J; Ray KK
JAMA Netw Open; 2018 Dec; 1(8):e185554. PubMed ID: 30646277
[TBL] [Abstract][Full Text] [Related]
19. Lifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities.
Halava H; Korhonen MJ; Huupponen R; Setoguchi S; Pentti J; Kivimäki M; Vahtera J
CMAJ; 2014 Sep; 186(12):E449-56. PubMed ID: 24958839
[TBL] [Abstract][Full Text] [Related]
20. Association between trajectories of statin adherence and subsequent cardiovascular events.
Franklin JM; Krumme AA; Tong AY; Shrank WH; Matlin OS; Brennan TA; Choudhry NK
Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1105-13. PubMed ID: 25903307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
